Madrid 23-27 October
We’re delighted to confirm that Morula Health will be attending the ESMO Congress 2026, taking place in Madrid from October 23 to 27.
This congress brings together global leaders in oncology, offering a valuable opportunity to connect with biotech and pharmaceutical teams advancing new therapies.
We will be available throughout the event to discuss how our medical writing expertise supports clinical development, regulatory submissions, and scientific communications across the full product lifecycle.
If you are attending ESMO 2026, we invite you to connect with Philip Burridge or Jed MacKenzie to explore how we can support your programs.
To arrange a meeting, please reach out in advance or connect with us during the congress.
“I’m looking forward to attending ESMO and meeting with both familiar faces and new connections across the oncology community. It’s always a fantastic opportunity to learn about the latest scientific advances, discuss industry challenges, and explore how we can support organisations developing the next generation of cancer therapies.” Philip Burridge, Director, Operations & Strategy
Get in touch
If you’d like to learn more about Morula Health’s medical writing services, from regulatory and clinical writing to specialist support across rare disease, oncology, and complex submissions, get in touch or explore our recent case studies to see how we support teams at every stage of development.
We look forward to the conversations ESMO 2026 will spark, and to bringing those insights back into the work we do with our clients.
Related Insights
FDA-aligned CSR and Narrative Writing Support for Complex Immuno-Oncology Programs
UK biotech transitioning from a freelance medical writer to a scalable partner, delivering FDA‑aligned immuno‑oncology CSRs and safety narratives to support US expansion. As program demands grew, they needed a partner who could scale alongside their increasing volume of deliverables.
Find out more
Redefining Therapeutic Potential: Large Oncology IND Submission
Morula Health supported a UK biotech with the delivery and management of a large oncology IND submission. Our regulatory medical writing expertise ensured consistency across complex documentation and supported a successful regulatory outcome.
Find out more
How Assessment Aids Can Help You Get Your Oncology Product Approved Faster
Find out more